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Background: In 2010, there were an estimated 15 million 
preterm births worldwide (<37 wk gestation). Survivors are at 
risk of adverse outcomes, and burden estimation at global and 
regional levels is critical for priority setting.
Methods: Systematic reviews and meta-analyses were 
undertaken to estimate the risk of long-term neurodevelop-
mental impairment for surviving preterm babies according to 
the level of care. A compartmental model was used to estimate 
the number of impaired postneonatal survivors following pre-
term birth in 2010. A separate model (DisMod-MR) was used 
to estimate years lived with disability (YLDs) for the global bur-
den of disease 2010 study. Disability adjusted life years (DALYs) 
were calculated as the sum of YLDs and years of life lost (YLLs).
results: In 2010, there were an estimated 13 million preterm 
births who survived beyond the first month. Of these, 345,000 
(2.7%, uncertainty range: 269,000–420,000) were estimated to 
have moderate or severe neurodevelopmental impairment, and 
a further 567,000 (4.4%, (445,000–732,000)) were estimated to 
have mild neurodevelopmental impairment. Many more have 
specific learning or behavioral impairments or reduced physical 
or mental health. Fewest data are available where the burden is 
heaviest. Preterm birth was responsible for 77 million DALYs, 3.1% 
of the global total, of which only 3 million were YLDs.
conclusion: Most preterm births (>90%) survive without 
neurodevelopmental impairment. Developing effective means 
of prevention of preterm birth should be a longer term priority, 
but major burden reduction could be made immediately with 
improved coverage and quality of care. Improved newborn 
care would reduce mortality, especially in low-income coun-
tries and is likely to reduce impairment in survivors, particularly 
in middle-income settings.
in 2010, there were an estimated 15 million preterm births worldwide, before 37 completed weeks of gestation (1). This 
represents a major burden worldwide, as preterm birth is asso-
ciated with many specific acute complications of immaturity 
including respiratory distress syndrome, intracranial hemor-
rhage, necrotising enterocolitis, and retinopathy of prematurity 
(ROP) (Figure 1 and Table 1). Direct complications of preterm 
birth were responsible for an estimated 35% of the world’s 3 mil-
lion neonatal deaths in 2010, making preterm birth the second 
most common cause of death in children under-five after pneu-
monia (2). Preterm birth also increases the risk of death due to 
other causes, especially neonatal infections (3,4). Hypothermia 
and malnutrition secondary to poor feeding further increase 
vulnerability. In almost all high- and middle-income countries, 
preterm birth is the leading cause of child deaths. The scale of 
this problem has recently been highlighted in the first national 
estimates of preterm birth prevalence and the in the linked 
“Born Too Soon” report which underlined that the vast major-
ity of these deaths occur in low–middle-income settings but are 
preventable without intensive care (1,5).
In addition to its contribution to mortality, preterm birth 
can have lifelong effects on neurodevelopment, with increased 
risks of cerebral palsy and impaired learning, mental disor-
ders, and physical health, which contribute to the prematurity-
related burden of chronic disease in adulthood (6) (Figure 1 
and Table 1). The risks are higher in those preterm who are 
also small for gestational age, or with associated infection (7). 
The economic cost of preterm birth is high in terms of neonatal 
intensive care, continuing healthcare, and special educational 
needs. The societal cost is also high, with many families experi-
encing the sudden loss of a preterm baby or a stressful hospital 
stay, sometimes for months, followed by lifelong effects (5).
This paper presents regional and global estimates of specific 
outcomes associated with preterm birth, including gestation-
specific case fatality and neurodevelopmental impairment. 
Estimates of ROP and visual impairment following preterm 
birth are presented in a further paper in the supplement (8). 
The global burden of disease (GBD) studies (9–11) underline 
the major contribution of preterm birth; however, details of 
the inputs, methods used, estimates of the proportions of live 
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births affected, survival by gestational age, and risk of disability 
have not been published since the 1996 GBD version (12). The 
Expert team for preterm birth involved in GBD2010 overlaps 
with the author group on this paper, and we discuss the param-
eter inputs and regional and global estimates of specific out-
comes associated with preterm birth in GBD2010. In addition, 
since the inputs were finalized for GBD2010, further data have 
been published, and additional data sets became available for 
analyses, for example, to improve the coverage of care assump-
tions used throughout this supplement. This is in the spirit 
of continually improving the input data. Where the inputs or 
methods differ from GBD, this will be noted (13).
Methods
Definitions
The World Health Organization (WHO) defines preterm birth as 
any birth before 37 completed weeks of gestation (fewer than 259 d 
since the first day of the women’s last menstrual period (14). This is 
commonly subdivided based on gestational age: extremely preterm 
(<28 wk), very preterm (28–31 wk), and moderate and late pre-
term (32–36 wk), since decreasing gestational age is associated with 
increasing mortality, disability, and a greater requirement for intensive 
neonatal care if survival is to be assured, with higher associated costs.
Estimating the burden of preterm birth is challenging due to the 
paucity of gestational age–specific data. Given the relatively recent rec-
ognition of the importance of gestational age rather than birth weight 
in determining outcome, most studies have presented data by birth 
weight alone. Widespread early ultrasound scanning has improved 
gestational age assessment in most high-income and many middle-
income countries. However, this requires skilled technicians equip-
ment and is most accurate when undertaken in the first trimester, 
limiting its use in many low- and middle-income settings. Without 
early ultrasound screening, gestational age assessment uses less-
accurate methods based on last menstrual period or newborn physi-
cal characteristics (15). When gestational age data were not available, 
we used commonly applied birth weight proxies, namely, <1,000 g for 
extremely preterm birth (<28 wk) and 1,000 to <1,500 g for very pre-
term birth (28–31 wk) (Supplementary Information online).
We estimated long-term (present at 2–5 y of age) mild and mod-
erate/severe neurodevelopmental impairment among postneonatal 
survivors of preterm birth. See Table 1 and the methods paper of this 
supplement for full definitions (13).
Data Searches and Meta-Analyses
A systematic literature review was undertaken of the main online lit-
erature databases including Pubmed/Medline, Embase, CAB abstracts, 
Popline, Web of Science, Cumulative Index to Nursing and Allied 
Health (CINAHL) Latin American and Caribbean Health Science 
(LILACS), and WHO Regional library databases, applying the general 
search strategy described in the methods paper of this supplement 
(13). Search terms used included multiple variants of terms covering 
the following areas “preterm/premature” and “birth/labor” or “new-
born/infant,” “mortality/death,” and “outcome/impairment” and used 
Medical Subject Headings terms when available (see Supplementary 
Information online for full details of search terms, dates, and inclu-
sion criteria). Snowball searching was used to identify additional 
studies by screening the reference lists of retrieved studies. Data were 
abstracted if the study fulfilled the inclusion criteria, regardless of the 
year of birth of the cohort. However, in view of the rapid changes and 
progress in neonatal intensive care in low mortality settings over the 
past decades, especially for the preterm baby, only studies with birth 
cohorts with a median year of 2000 or later were included in the main 
analysis. Data on the outcome of preterm-born neonates with congeni-
tal abnormalities were excluded.
Standard meta-analysis techniques were used to obtain summary 
estimates of the parameters of interest including neonatal CFR, gen-
der, and risk of impairment by gestational age and access to care 
(Figure 2). Heterogeneity across studies was assessed using I2 and the 
χ2 test. Where evidence of heterogeneity was present (I2 > 70% or P < 
0.05), a random-effects meta-analysis model was used.
Overview of Modeling Approach
A three-step compartmental model was constructed, using the esti-
mated input parameters to estimate neurodevelopmental impair-
ment among postneonatal survivors of preterm birth (Figure 2) (13). 
This approach differs from GBD2010 in that the focus is on 2010 
without estimating time trends for the condition or for sequelae. 
The methods applied in GBD are summarized in the methods paper 
of this supplement and detailed elsewhere (13,16). In step 1, we esti-
mated the prevalence of preterm birth among live births, by sex, as 
this is a determinant of mortality and morbidity outcomes. In step 
2, we estimated the number of postneonatal survivors, and in step 
3, the number of these survivors who were impaired (Figure 2). The 
steps of the compartmental model were applied in sequence for the 
live births in each country with more than 10,000 births for the year 
Figure 1. Disease schema for sequelae of preterm birth.
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2010 (17). Unpublished data for the same live birth series was used 
to estimate the number of live births by sex. All results are presented 
at the regional level using the GBD super-regional grouping (13).
We quantified the uncertainty surrounding these estimates by tak-
ing 1,000 random draws of the input parameters at each step, assum-
ing a normal distribution with mean equal to the point estimate of 
the parameter and SD equal to the estimated standard error of the 
parameter. We summed the data at worldwide or regional level for 
each draw and present the 2.5th and 97.5th percentiles of the resulting 
distributions as the uncertainty range.
results
A total of 14,929 titles and abstracts were reviewed, and 862 
studies contributed to the estimation of one or more parameters. 
A summary of all the parameter values used is given in Table 2 
(see also Supplementary Information online). A summary of 
the regional results is given in Table 3.
Step 1: Preterm Live Birth Prevalence
Preterm live birth prevalence. National preterm birth rates 
for 2010 were estimated using two regional multilevel sta-
tistical models including data from national registries or 
statistical offices, Reproductive Health Surveys, unpub-
lished data, and published papers identified through a sys-
tematic review. These included 738 reported data inputs 
from 99 countries, with the majority (547/738) of the data 
table 1. Definitions 
Brief definition/explanation ICD-10 codes and categories
Preterm birth Live birth before 37 completed weeks of gestation, or fewer than  
259 d since the first day of the women’s last menstrual period
P07.20–P07.39
Immediate complications of preterm birth
 Stillbirth Fetal death after 22 wk of completed gestation, using after 28 wk or 
1,000 gms for international estimates and comparison
P95
  Respiratory distress syndrome of the 
newborn
Breathing difficulty caused by deficiency of surfactant, also known as 
hyaline membrane disease
P22.0, P22.8, P22.9
  Intracranial nontraumatic hemorrhage of 
newborn
Bleeding into the brain with no history of birth or post delivery trauma P52.0–P52.9
 Necrotizing enterocolitis The inflammatory gastrointestinal entity that typically causes feed 
intolerance, abdominal distension, and intestinal bleeding and can 
lead to intestinal perforation and peritonitis
P77.1–P77.9
 Retinopathy of prematurity Abnormal blood vessel development in the retina of preterm babies 
that can lead to severe myopia and blindness
H35.10–H35.17
Long-term complications in survivors of 
preterm birth
 Cognitive impairmenta Cognitive Z-score:
 Mild: −1 to −2 SD for test (DQ 70–84)
 Moderate: −2 to −3 SD for test (DQ 55–69)
 Severe: ≤−3 SD for test (DQ <55)
Mild: Difficulty in everyday motor activities, but able to move around 
without help
Moderate: Difficulty in holding implements, dressing, and sitting 
upright. Able to move around with help
Severe: Inability to walk and absence of functional use of hands
Audiometric hearing threshold level: Mild: 26–30 dBHL, Moderate: 
35–64.9 dBHL, Severe >65 dBHL
Visual acuity in the best eye:
 Mild: <6/12 but better or equal to 6/18
 Moderate: 6/18 but better or equal to 6/60
 Severe: <6/60
F70–F79, F80.0, F81.0, F81.2, 
F81.8, F81.9, F06.7
G80, G81.1, G82.1, G83.0–
G83.3, G24.9, G25.3, G25.5, 
G25.9, F82, R26–R27
H90.3–H90.7
H47, H48–H51, H53.0, H53.2, 
H53.4, H54.4–H54.7
 Motor impairmenta
 Hearing impairmenta
 Visual impairmenta
 Adverse behavioral outcome in childhood Difficulties with attachment, socialization, attention, feeding and 
hyperactivity
F90–98
  Adverse mental health including psychotic 
and mood disorders
Anxiety and depression, neuroses, psychogenic symptoms, 
compulsive obsessive disorder, psychosis and schizophrenia
F20–F48
  Adverse respiratory outcomes including 
asthma and chronic obstructive 
pulmonary disease
Reduced lung function. Lifelong predisposition to 
bronchoconstriction and lung infection
J44–J45
  Adverse vascular health including 
hypertension, reduced renal function
Increased blood pressure and the consequences of this on 
cardiovascular and renal function
I10
aMild neurodevelopmental impairment is defined as any two domains mildly affected. Moderate/severe impairment is defined as any domain moderately or severely affected, or three 
domains mildly affected. See introduction paper in supplement for full definitions (13).
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inputs coming from high-income countries. Full details of 
the searches, methodology input data, statistical modeling, 
and results have been published elsewhere, including the 
estimates for 2010 for 184 countries and time trends for 65 
countries (1).
Gestational age subdivisions. The distribution of preterm 
births by gestational age subgroup was estimated from a meta-
analysis of 345 data points (131 million live births) (1). Based 
on these studies, we estimate that 5.2% (95% CI: 5.1–5.3%) 
of all preterm births were at less than 28 wk; 10.4% (95% CI: 
10.3–10.5%) at 28–31 wk and 84.3% at 32–36 wk (95% CI: 
84.1–84.5%). Eighty-five percent of those born at 32 wk or 
more were born between 34–36 wk.
Sex differences in preterm live-birth prevalence. Data from 
13 studies from the United States/Europe suggest that 54.6% 
(95% CI: 53.9–55.4%) of preterm births are in males and 
that risk ratio for preterm birth among males compared with 
females is 1.14 (95% CI: 1.11–1.17) (Table 2; Supplementary 
Information online) No data fulfilling the inclusion crite-
ria were available from middle- or low-income settings, and 
therefore, the male to female risk ratio for preterm birth was 
assumed to be constant across all countries in all regions. The 
sex-specific prevalence of preterm birth was estimated by first 
calculating the absolute risk of preterm birth in males and 
females and applying this to the sex-specific live-birth data by 
country (see Supplementary Information online).
Prevalence estimates. We estimate that of the 14.9 million pre-
term births (uncertainty range: 12.3–18.1 million) in 2010, 8.2 
million (54.9%. 7.4–9.5 million) were males (Figure 3). An 
estimated 0.8 million (0.8–0.9 million) were <28 wk, 1.6 mil-
lion (1.5–1.7 million) were 28–31 wk, and 12.6 million (12.3–
14.0 million) were 32–36 wk.
Step 2: Calculation of the Number of Postneonatal Survivors
Effect of sex on case fatality rate. While evidence supports 
lower survival for male neonates at all gestations when com-
pared with females, insufficient data were available to include 
sex-specific mortality risks in the model (18–20).
Coverage and quality of care. We used the country neonatal 
mortality rate (NMR) as a proxy for access to and quality of 
newborn care and classified countries into three categories 
(Table 2) (13). We considered three care scenarios:
1. Full availability of all levels of neonatal care (including 
neonatal intensive care unit (NICU));
2. Some availability of specialized neonatal care (including 
neonatal special care), and
3. No access to NICU or neonatal special care, since out-
comes after preterm birth are highly dependent on both 
gestational age and the quality of care received.
See the methods paper of this supplement (13) and 
Supplementary Information online for further details.
Figure 2. Compartmental model: Parameters required and methods for estimation of the global burden of impairment related to preterm birth for the 
estimation of impairment after preterm birth.
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table 2. Countries (184) according to level of neonatal mortality, showing a summary of input data to the compartmental model for preterm 
around the year 2010 
Countries according to level of NMR
NMR <5 NMR 5 to <15 NMR ≥15
Level 1 Level 2 Levels 3/4/5
No. of countries in 2010 46 62 76
No. of live births in 2010 13,261,000 40,271,000 81,148,000
Step 1 Preterm birth prevalence 
data (per 100 live births)
30 countries 28 countries 41 countries
415 datasets 187 datasets 136 datasets
N = 11.0 million N = 5.2 million N = 1.9 million
Data range: 4.1–16.4% Data range: 3.1–19.5% Data range: 3.5–28.5%
Median: 6.8% Median: 5.9% Median: 8.5%
Gestational age 
subdivisions
345 data points;  <28 weeks: 5.2% (95% CI: 5.1–5.3%);  28–31 weeks: 10.4% (95% CI: 10.3–10.5%);   
and 32–36 weeks: 84.3% (95% CI: 84.1–84.5%)
Relative risk of preterm 
birth for males 
compared to females
10 countries;  13 datasets;  N (live births) = 8.6 million;  pooled estimate: 1.14;  and  (95% CI: 1.11–1.17)
Step 2 Gestation-specific 
preterm birth case 
fatality risk (per 100 live 
births in gestational age 
group)
21 countries 38 countries
36 datasets 40 datasets
N (preterm births) = 388,253 N = 140,203
Whole population Limited basic care Neonatal special care NICU
<28 wk, 
28–31 wk, 
and 
32–36 wk
28.3%  
(95% CI: 25.4–31.2%)
99%  
(95% CI: 98–100%)
86.4%  
(95% CI: 78.9–93.9%)
51.7%  
(95% CI: 43.3–60.0%)
5.8%  
(95% CI: 5.1–6.5%)
61.4%  
(95% CI: 55.5–67.3%)
41.3%  
(95% CI: 36.8–45.9%)
NMR 5 to <15: 15.3% 
(95% CI: 9.9–20.6%)
NMR ≥15: 28.8%)  
(95% CI: 25.2–32.5%)
0.7%  
(95% CI: 0.6–0.8%)
Assumed to be the country NMR *2.05 (95% CI: 1.55–2.70)
Step 3 Risk of moderate/
severe long-term 
neurodevelopmental 
impairment after 
preterm birth (per 100 
preterm survivors in 
gestational age group)
17 countries, 20 datasets,  N 
(survivors) = 9,369
7 countries, 7 datasets, and N (survivors) = 498
<28 wk,  
28–31 wk, 
and  
32–36 wk
24.5%  
(95% CI: 20.2–28.8%)
All <32 wk: 24.6% (95% CI: 15.3–33.9%)
12.2%  
(95% CI: 6.1–18.2%)
1.8%  
(95% CI: 1.5–2.3%)a
No data. Assume 1.8% as per low mortality settings
Risk of mild long-term 
neurodevelopmental 
impairment after 
preterm birth (per 100 
preterm survivors in 
gestational age group)
9 countries, 23 datasets, and  
N (preterm births) = 19,191
4 countries
4 datasets
N = 237
<28 wk,  
28–31 wk, 
and 
32–36 wk
33.9%  
(95% CI: 28.6–39.3%)
All <32 wk: 32.4% (95% CI: 15.4–49.4%)
16.5%  
(95% CI: 13.6–19.3%)
3.4%b  
(95% CI: 2.5–4.4%)
No data. Assume 3.4% as per low mortality settings
CI, confidence interval; NICU, neonatal intensive care unit; NMR, neonatal mortality rate.
aAssuming 85% of those 32–36 wk are 34–36 wk (see gestational age subdivisions) and 32–33 wk = 8.2% (95% CI: 6.5–10.1%) and 34–36 wk = 0.7% (95% CI: 0.6–0.9%). b32–33 wk = 15.9% 
(95% CI: 11.1–20.7%) and 34–36 wk = 1.2% (95% CI: 1.0–1.5%).
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Gestation-specific case fatality rate by NMR group, gestational 
age category and level of care available. These are summarized 
in Table 2.
Low-mortality countries (NMR < 5): population-based 
approach for all gestational ages: For low mortality coun-
tries, gestational age–specific neonatal mortality data were 
abstracted from cohort studies identified from searches, pre-
dominantly from NICU, assuming all live-born neonates 
under 32 wk in these countries have access to NICU. Further 
searches of statistical databases, including EURO-PERISTAT 
(21) were used to provide population-based data from coun-
tries with more advanced statistical reporting systems and for 
those born at 32–36 wk. Case fatality risk (CFR) was estimated 
as 28.3% (95% CI: 25.4–31.2%) for those born at <28 wk; 5.8% 
(95% CI: 5.1–6.5%) for those born at 28–31 wk; and 0.7% (95% 
CI: 0.6–0.8%) of those born at 32–36.
Higher mortality countries (NMR ≥ 5): population-based 
approach for those born at 32–36 wk: for higher mortality 
countries, population-based data on neonatal survival of those 
born preterm are limited. Data from principle investigators 
collaborating with the Child Health Epidemiology Research 
Group SGA-Preterm Working Group provided mortality data 
from 19 low- and middle-income country birth cohorts by ges-
tational age bands: <32 and 32–36 wk (22). Neonatal CFR for 
neonates born at 32–36 wk is less dependent on availability of 
intensive care and is mainly affected by basic hygiene, thermal 
care, extra support for breast feeding, and prompt recognition 
and treatment of infections. Hence, the survival of this group 
is closely related to the population NMR and showed a consis-
tent relationship across these 19 studies with a pooled neonatal 
mortality risk ratio of 2.05 (95% CI: 1.55–2.70) for neonates 
born at 32–36 wk as compared with all neonates. This risk ratio 
was applied to the NMR for each country to estimate the num-
ber of 32–36 wk preterm deaths by country.
Higher mortality countries (NMR ≥ 5): approach based on 
level of care available for those born at <32 wk: Survival at 
<32 wk is highly dependent on the care available. In many 
high-mortality settings, most of these births will be at home, 
without gestational age assessment, access to specialist hospi-
tal care, or birth registration. Population-based data for these 
babies are problematic, with many community-based studies 
reporting implausibly high neonatal survival rates among very 
preterm neonates with limited availability of care, likely due to 
missed early neonatal deaths (22,23).
For neonates with basic/limited care only, survival for 
those born at <28 wk is uncommon. We assumed that 99% 
of all  neonates born at <28 wk with no access to neonatal 
special care would die. For babies born at 28–31 wk, we 
estimate 61.4% (95% CI: 55.5–67.3) neonatal mortality based 
on one multisite trial including 96 rural sites in 7 countries 
(24). We note that this is an underestimate since neonatal 
deaths occurring after the first 7 d were not captured in this 
study.
For babies with access to special care only without inten-
sive care, the estimated neonatal mortality was 86.4% (95% 
CI: 78.9–91.9%; 3 studies) for those born at <28 wk and 41.3% 
(95% CI: 36.8–45.9%; four studies) for those born at 28–31 wk 
(Supplementary Information online).
With access to NICU care, no strong evidence of a difference 
in mortality for neonates born at <28 wk was found between 
NMR 5 to <15 and NMR ≥15 countries, and the pooled esti-
mate of 51.7% (95% CI: 43.3–60.0%; 17 studies) was used for 
all neonates with access to NICU in countries with NMR ≥5. 
For neonates born at 28–31 wk with access to NICU care, the 
pooled estimate of mortality was 15.3% (95% CI: 9.9–20.6%; 
10 studies) in NMR 5 to <15 countries and 28.8% (95% CI: 
25.2–32.5%; 5 studies) in NMR ≥15 countries.
Estimates of the number of postneonatal survivors. An estimated 
4.3 million preterm neonates had access to NICU care if required 
(28% of all preterm live births), 2.5 million (17%) to special care 
only, and 8.2 million (55%) to basic/limited care only.
A total of 2.0 million (uncertainty range: 1.9–2.2 million) of 
those born preterm are estimated to have died during the first 
month of life comprising 642,000 babies (613,000–717,000) 
born at <28 wk; 702,000 babies (653,000–810,000) born at 
28–31 wk; and 645,000 babies (585,000–757,000) born at 
32–36 wk. 1.5 million (75%) of these deaths are estimated to 
have occurred in sub-Saharan Africa or South Asia (Table 3). 
This leaves an estimated 13 million (12.7–14.3 million) post-
neonatal preterm survivors; 140,000 (130,000–170,000) born 
at <28 wk; 857,000 (821,000–976,000) born at 28–31 wk; and 
12.0 million (11.6–13.2 million) born at 32–36 wk.
Step 3: Calculation of the Number of Impaired Survivors
Sex-specific impairment risk. Although evidence supports 
increased neonatal morbidity and long-term neurodevelop-
mental impairment for males at all gestations when compared 
with females, insufficient data were available to include sex-
specific risks in the model (19,25).
Gestation-specific impairment risk by NMR group, gestational 
age category, and level of care. Twenty-six studies reporting 
neurodevelopmental outcomes were included from the searches 
described above. Data were pooled in meta-analyses by NMR 
group. (Table 2 and Figures 4–6; Supplementary Information 
online) The median age at assessment was 28 mo. The propor-
tion of surviving neonates who developed neurodevelopmental 
impairment did not vary in a consistent way across studies with 
differing lengths of follow-up. Where follow-up studies reported 
neurodevelopmental impairment in survivors who were assessed 
at several different time points, the data from the assessment near-
est to 5 y of age were used, to provide a balance between increas-
ing loss to follow-up in cohorts over time, and concordance of the 
developmental assessment with later neurodevelopmental and 
school outcome (26). This may underestimate the risk and sever-
ity of impairment for all postneonatal survivors, since the most 
severely impaired survivors have increased risk of death in child-
hood and hence may be underrepresented in the follow-up stud-
ies used to estimate the risk of impairment. Exclusion of studies 
with >30% loss to follow-up did not affect the overall result, and 
hence, no study was excluded on this basis to minimize data loss.
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table 3. Estimated number of preterm births, deaths, and impaired survivors by region in 2010 with YLDs and total DALYs from preterm birth at 
all ages GBD 2010
High income
Eastern 
Europe/
Central Asia
Latin 
America and 
Caribbean
East–Southeast 
Asia and Pacific
North Africa 
and Middle 
East South Asia
Sub-Saharan 
Africa Total
Number of live births 11.7 million 5.4 million 9.9 million 29.0 million 9.7 million 37.1 million 32.1 million 135 million
% of worldwide total 9% 4% 7% 22% 7% 28% 24% 100%
Number of preterm 
births (uncertainty 
range)
1,064,000  
(1,047,000–
1,124,000)
413,000 
(333,000–
517,000)
851,000  
(680,000–
1,222,000)
2,808,000 
(2,057,000–
3,560,000)
911,000 
(665,000–
1,214,000)
4,954,000  
(3,724,000–
6,256,000)
3,935,000  
(3,038,000–
5,064,000)
14,900,000  
(12,300,000–
18,200,000)
% of worldwide total 7% 3% 6% 19% 6% 33% 26% 100%
Number of neonatal 
deaths in babies born 
at <37 wk (uncertainty 
range)
30,200  
(28,700–
32,700)
27,900 
(27,300–
34,600)
70,300  
(69,900–
85,000)
272,800 
(254,900–313,500)
96,500 
(94,000–
120,000)
818,900  
(717,300–
914,500)
669,600  
(669,500–
781,600)
1,985,600  
(1,942,000–
2,191,000)
% of worldwide total 1% 1% 4% 14% 5% 41% 34% 100%
Number of survivors 
with severe impairment 
(uncertainty range)
39,600  
(31,600–
472,000)
16,600 
(13,000–
21,700)
30,500  
(23,500–
40,600)
82,300 (62,300–
100,400)
25,100 
(19,600–
32,000)
86,100  
(58,200–
107,200)
64,500  
(48,300–
87,400)
344,700  
(269,000–420,100)
% of worldwide total 12% 5% 9% 24% 7% 25% 19% 100%
Number of survivors 
with mild impairment 
(uncertainty range)
61,500  
(52,700–
72,500)
24,600 
(19,000–
34,400)
45,700  
(35,400–
65,200)
128,700  
(97,400–168,900)
39,600 
(31,000–
54,100)
151,500  
(104,500–
199,300)
115,500  
(90,300–
165,000)
566,700  
(444,600– 
731,900)
% of worldwide total 11% 4% 8% 23% 7% 27% 20% 100%
GBD 2010 Estimated 
YLDs due to prematurity 
in thousands 
(uncertainty range)
380  
(270–500)
140  
(100–190)
220  
(160–290)
820  
(600–1,080)
180  
(130–230)
860  
(610–1,150)
380  
(280–470)
2,980  
(2,280–3,770)a
% of worldwide total 12% 5% 7% 27% 6% 29% 13% 100% 
GBD 2010 Estimated 
DALYs due to preterm 
birth in thousands 
(uncertainty range)
2,200  
(1,900–2,600)
1,500 (1,200-
1,800)
3,900  
(3,400-4,600)
7,800 (6,700- 
9,300)
4,600 (3,900-
5,500)
37,000  
(29,000-
45,000)
20,000  
(16,000-
24,000)
77,000  
(66,000- 
88,000)
% of worldwide total 3% 2% 5% 10% 6% 48% 26% 100%
Percentage of DALYs 
that are from YLDs
16.2% 9.5% 5.3% 10.4% 4.0% 2.3% 1.9% 3.9%
DALYs, disability adjusted life years; GBD, global burden of disease; YLD, years lived with disability.
aIncluding 347 (212–508) from isolated visual impairment from retinopathy of prematurity.
Figure 3. Number of preterm births in 2010 for world region according to the sex of the baby. Males are shown in dark gray, females in light gray.
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(i) Low mortality countries (NMR <5): We estimate that 
24.5% (95% CI: 20.2–28.8%) of survivors born at <28 wk had 
moderate/severe neurodevelopmental impairment (16 studies, 
Figure 4) and 33.9% (95% CI: 28.6–39.3%; 7 studies) of survi-
vors had mild neurodevelopmental impairment.
For those born at 28–31 wk, 12.2% (95% CI: 6.1–18.2%; 3 
studies) had moderate/severe and 16.5% (95% CI: 13.6–19.3%; 
1 study) mild neurodevelopmental impairment. These stud-
ies showed substantial heterogeneity; the majority of studies 
were of neonates admitted to tertiary NICUs, some of which 
reported higher risk of impairment than the few studies from 
geographically defined populations.
Since most neonates born at 32–36 wk will not require NICU 
care, we used population-based studies only to assess the risk 
of neurodevelopmental impairment in those born moderately 
and late preterm. Several large birth cohorts from pre-1990 
were excluded as the neonatal practices at the time are likely 
to have been very different from those in 2010, used mostly 
national registry data to capture outcomes, and only included 
survivors to adulthood (27–29). No population-based stud-
ies were available providing details for the whole group of 
32–36 wk. We therefore used separate studies to estimate risk 
in those surviving moderate (32–33 wk) and late (34–36 wk) 
preterm birth. We assumed 15% of the whole 32–36 group to 
be born at 32–33 wk (see above). We used data from a large 
prospective population-based study of neonates 34–36 wk of 
gestation from the United States (30) providing risks based on 
a hierarchy of motor and cognitive impairments. 0.7% (95% 
CI: 0.6–0.9%) had “moderate/severe motor delay,” used here 
as a proxy for moderate/severe neurodevelopmental impair-
ment. This does not include those with isolated moderate/
severe cognitive impairment and hence will underestimate 
this risk. An additional 1.2% (95% CI: 1.0–1.5%) had “isolated 
cognitive impairment/developmental delay,” used here a proxy 
for isolated mild neurodevelopmental impairment. This may 
be an overestimate as it includes those with more severe iso-
lated cognitive impairment but does not include isolated mild 
motor delay. For those born at 32 and 33 wk, we used popu-
lation-based cognitive outcome data from EPIPAGE where 
8.2% (95% CI: 6.5–10.1%) had moderate/severe and 15.9% 
(95% CI: 11.1–20.7%) mild neurodevelopmental impairment 
(31) (Table 2). These rates of neurodevelopmental impairment 
were similar to those reported in survivors born at 32–35 wk 
in a large community-based cohort in the Netherlands who 
were assessed by parental questionnaire around 46 mo of age 
(32,33).
(ii) Higher mortality countries (NMR ≥5): No data 
reported outcomes separately for those born at <28 wk and 
at 28–31 wk. For those born at <32 wk gestation, 7 studies 
from NICU settings suggested a wide variation in risks of 
moderate or severe neurodevelopmental impairment in 
postneonatal survivors, ranging from 11.7 to 45.0% (pooled 
estimate: 24.6% (95% CI: 15.3–33.9%); Table 2). Four stud-
ies on mild impairment in infants born at <32 wk were 
identified, producing a pooled estimate of 32.4% (95% CI: 
15.4–49.4%).
Data on long-term risk of neurodevelopmental impairment 
after very preterm birth (<32 wk) are only available for survi-
vors in high-mortality settings who have benefited from NICU 
care. The risk of neurodevelopmental impairment in the few 
very preterm neonates who survive the neonatal period with-
out access to NICU care is likely to be lower, given the sub-
stantial mortality risk in this group and those who survive 
are a relatively more mature population with less immediate 
morbidity. We assumed, as a conservative estimate, the risk 
of impairment postneonatal survivors born at <32 wk without 
access to NICU care to be as a minimum the same as the risk 
for those born at 32–36 wk in high-income settings (Table 2).
Increasing evidence suggests a small but significant risk 
of neurodevelopmental impairment after late preterm birth, 
even in the absence of acute neonatal complications. No pop-
ulation-based data on the risk of long-term impairment after 
moderate-to-late preterm birth was available from high-mor-
tality settings. Hence, we assumed that the impairment rate for 
those surviving moderate-to-late preterm birth to be similar 
to that from population-based data for postneonatal survivors 
born at 32–36 wk in high-income settings (Table 2).
Estimates of the number of impaired survivors. We estimate 
that at least 911,000 (uncertainty range: 775,000–1,102,000) of 
postneonatal preterm survivors (7%) suffer long-term neuro-
developmental impairment. This comprises 345,000 (uncer-
tainty range: 269,000–420,000) who are moderately or severely 
affected and a further 567,400 (445,000–732,000) with mild 
neurodevelopmental impairment. Worldwide, 52% of those 
born at <28 wk, 24% of those born at 28–31 wk, and 5% of 
those born at 32–36 wk and surviving the neonatal period are 
estimated to have some degree of neurodevelopmental impair-
ment (Figure 7).
GBD2010-Specific Inputs, Methods, and Results
GBD2010 used an approach similar to the three steps defined 
above to estimate the number of impaired survivors after pre-
term birth but for 1990–2010 (as opposed to 2010 only).
Key differences between the three steps between GBD2010 and 
the compartmental model. With respect to data inputs, the 
final date of the searches for the inputs to GBD2010 was June 
2011 and hence did not include additional data published after 
this date which was available for the compartmental model 
presented here only. GBD2010 used risk of impairment data 
from 34–36 wk group to apply to the entire 32–36 wk group. 
Regarding GBD methods, a single pooled estimate of CFR 
and risk of impairment by gestational age category was used 
for all neonates in a given NMR group and did not take access 
to neonatal care into account. Hence, the estimated number of 
preterm births by region in GBD2010 was slightly lower but 
within the uncertainty range when compared with the method 
described in this paper. The estimated number of impaired 
survivors was lower in all regions in the GBD2010 model. The 
higher estimates in the compartmental model are primarily 
driven by the revised CFR by level of care assumptions which 
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estimates fewer deaths at all gestational ages in the highest 
burden regions and the increased impairment risk from using 
new gestation-specific data for those born at 32 and 33 wk in 
all regions (Supplementary Information online). If these revi-
sions were taken into account in GBD, the estimated number of 
years lived with disability (YLDs) may be substantially higher.
Figure 4. Meta-analysis of studies reporting moderate/severe impairment outcomes for babies born at less than 28 wk in countries with neonatal mortal-
ity rate (NMR) <5 in 2000–2010.
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Figure 5. Meta-analysis of studies reporting moderate/severe impairment outcomes for babies born at 28–31 wk in countries with neonatal mortality 
rate (NMR) <5 in 2000–2010.
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Figure 6. Meta-analysis of studies reporting moderate/severe impairment outcomes for babies born at less than 32 wk in countries with neonatal mortal-
ity rate (NMR) ≥5 in 2000–2010.
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Figure 7. Worldwide deaths and disability for babies born preterm in 2010.
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Estimates shown are all from the 3 step compartmental model outlined in this article. Note that the mortality estimates here refer to all deaths in preterm babies, not
preterm specific complications as a direct cause of death, which the United Nations estimates at one million deaths and GBD2010 suggests 900,000. Furthermore,
a compartmental model and case fatality risk (CFR) are more uncertain for cause of death estimation. Given these considerations the estimates are consistent with
an estimate of preterm birth as risk factor for neonatal mortality, but a full comparative risk analysis is the next step. GBD, global burden of disease.
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GBD2010 included three further steps beyond the compart-
mental model described above:
1. A Bayesian meta-regression method developed for the 
GBD, DisMod-MR, was used to estimate the preva-
lence of long-term impairments in 2010 by age, sex, 
and country including additional data regarding excess 
mortality risk in impaired survivors (13).
2. The number of YLDs at all ages were calculated as the 
prevalence of impaired survivors at all ages multiplied 
by the disability weight scores derived for the GBD2010 
study (13,34). In DisMod-MR, all preterm births with 
moderate-to-severe outcomes were modeled together. A 
Swedish register of 90 children with cerebral palsy due to 
preterm birth was used to apportion the distribution of 
severity to motor impairment, cognitive impairment, sei-
zure disorder, blindness, and possible combinations (35).
  The final disability weight used for moderate-to-
severe neurodevelopmental impairment for high-
income regions was 0.38 (uncertainty range: 0.29–0.49) 
and 0.42 (uncertainty range: 0.32–0.53) in low- and 
middle-income regions. The higher disability weights 
in low- and middle-income regions are because the 
epilepsy disability weights distinguish those with and 
without treatment differently. Separate calculations were 
made for ROP, but disability for vision loss was only 
awarded to an estimated proportion of isolated cases 
of ROP without any other impairments as blindness in 
those with other impairments was taken into account in 
a combined disability weight for all moderate to severely 
impaired cases. Mild outcomes were modeled separately 
assuming that 50% of those with mild impairment had 
isolated mild motor problems, and 50% had mild motor 
and mild cognitive impairment. The final disability 
weight used for mild neurodevelopmental impairment 
was 0.03 (uncertainty range: 0.02–0.05).
3. The number of disability adjusted life years (DALYs) 
were then calculated as the sum of years of life lost 
(YLLs) due to premature mortality from preterm birth 
and YLDs (11,13). YLLs for preterm birth in 2010 
were calculated for GBD2010 using the Cause of Death 
Ensemble model (CODEm) and standard life expec-
tancy tables (13,36). This includes deaths at all ages 
due to direct complications of preterm birth only and 
is based on 3,363 vital registration, 225 verbal autopsy, 
and 25 surveillance data sources.
Estimates of the number of YLDs and DALYs associated with 
preterm birth.  3.0 million YLDs (uncertainty range: 2.2–3.7 
million) and 74.0 million YLLs (63.0–85.2 million) giving a total 
of 77.0 million (66.0–88.0 million) preterm birth associated 
DALYs worldwide in 2010 (Table 3). This includes 0.3 million 
YLDs (0.2–0.5 million) due to visual impairment from “iso-
lated” ROP in children with no other impairments. Sub-Saharan 
Africa and South Asia have high population levels, preterm 
birth rates, and NMRs and accounted for nearly three-quarters 
of these DALYs, reflecting their high-mortality rates. YLDs 
accounted for just 2.2% of DALYs in these regions as compared 
with 9.5% in Latin America, 10.4% in East Asia and Pacific, and 
16.2% in high-income regions, reflecting a shift in burden from 
mortality to long-term impairment in the latter regions.
discussion
Of 15 million (12.3–18.2 million) preterm births in 2010, 13.0 
million (12.7–14.3 million) were estimated to survive the neona-
tal period. An estimated 0.9 million (uncertainty range: 0.8–1.1 
million) of these postneonatal survivors will suffer long-term 
neurodevelopmental impairment with 345,000 (uncertainty 
range 269,000–420,000) moderately or severely affected. There 
is a well-recognized gradient of increasing risk of mortality and 
adverse developmental outcomes with decreasing gestational 
age at birth from early term (37–38 wk) through to the most 
premature survivors (32,37–42). Preterm brain injury results 
from developmental vulnerability given that the brain weighs 
only 65% of its full-term weight at 34 wk and glial cell migration 
continues to 36 wk (43) and compounded by brain injury asso-
ciated with neonatal complications such as respiratory distress/
hypoxemia, infection, hyperbilirubinemia, and hypoglycemia 
(44–47). Those born preterm are at higher risk of having com-
plex medical, psychological, educational, and socioeconomic 
needs, placing a burden on both families and communities even 
in high-income settings (48–50). Few reports have quantified 
the long-term excess postneonatal mortality among impaired 
survivors in low- and middle-income settings; however, this is 
likely to be high given seizures, aspiration pneumonia, feeding 
difficulties, and potentially by reduced care-seeking practices.
Our CFR-based estimates suggests that ~2.0 million pre-
term neonates born in 2010 died during the first month of 
life both from direct complications of preterm birth (most 
deaths in those born at <32 wk) and from other causes where 
preterm birth was a risk factor (Figure 8). Caution should 
be applied in interpreting these results since CFR-based esti-
mates are more uncertain than multi-cause mortality data 
approaches. However, these are consistent with estimates of 
neonatal deaths due to direct complications of preterm birth 
in 2010 (1.1 million (2) or 0.84 million (36)) when combined 
with previous global estimates of the indirect effect of preterm 
birth (4,51). Deaths among neonates born at <32 wk are most 
likely to be coded (correctly) as direct preterm deaths, and 
the CFR approach suggest ~1.2 million which is within the 
uncertainty range of the current estimates. Currently, even in 
high-income countries with good vital registration systems, 
live-births at <28 wk are often classified as nonviable miscar-
riages (52). Neonatal deaths in those born at 32–36 wk are 
more likely to be coded (appropriately) to other causes, such 
as infection, with prematurity as a risk factor. Our finding 
suggests that two-third of all neonatal deaths may be in those 
born preterm, in line with previous global estimates and with 
the United States, where preterm birth is a direct cause of 
36% of all infant deaths, but two-thirds of all infant deaths 
were among babies who were born preterm (53). A formal 
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comparative risk factor analysis would be of value and should 
be linked with assessment of Small for Gestational Age (54).
The majority of preterm babies survive without impair-
ment, but at <28 wk gestation, over half (52%) are estimated 
to have some long-term impairment if they survive the neo-
natal period (Figure 7). Worldwide in 2010, 5% of those born 
at 32–36 wk who survive the neonatal period are estimated to 
have some degree of long-term impairment, but this includes 
85% of all 15 million preterm births, and hence, their contri-
bution to the overall burden is substantial (45,46). However, 
global averages mask considerable regional differences: 52% 
of all live births, 60% of preterm births, and 75% of neona-
tal deaths in those preterm born are estimated to occur in 
sub-Saharan Africa and South Asia but only 46% of impaired 
postneonatal survivors (Figure 8). A baby born alive before 
32 wk of gestation has a 53% chance of surviving the neonatal 
period without later neurodevelopmental impairment in high-
income regions, as compared with just 27% if born in South 
Asia or sub-Saharan Africa. These differences are mainly due 
to a marked survival gap and access to neonatal care between 
low- and high-income regions. The burden of impairment is 
disproportionately heavier in middle-income regions, which 
account for 33% of preterm births, 23% of the deaths, but 43% 
of the impairment. In countries scaling up NICU, urgent atten-
tion to quality of care is required to minimize impairment.
These estimates considered a defined group of neurode-
velopmental disorders only, long-term sequelae of preterm 
birth are much wider than these. Many studies have reported 
an association of preterm birth with specific learning and 
executive function impairments and adverse mental health 
outcomes, including attention-deficit hyperactivity disorders, 
autistic spectrum disorders, anxiety/emotional disorders, and 
probably schizophrenia, particularly in those born very pre-
term (55–68). These deficits are also increasingly being recog-
nized in late preterm infants (27,37,69–73).
A large population-based cohort study in the United 
Kingdom reported that as well as neurodevelopmental impair-
ment other health outcomes were worse in those born preterm 
at any gestation than their term-born peers (38). Preterm birth 
at all gestations is linked to adverse long-term respiratory and 
cardiovascular outcomes (74,75). Babies who develop chronic 
lung disease after bronchopulmonary dysplasia have reduced 
lung function and lower exercise tolerance, placing them at 
higher risk of symptomatic chronic obstructive disease in 
middle adulthood than a term-born child (76–78). Even in the 
absence of chronic lung disease, preterm-born children were 
also more likely to have asthma and reduced lung function at 
school age as compared with their term-born peers (38,79). 
A recent meta-analysis shows that preterm birth is associ-
ated with substantially higher blood pressure in adult life and 
with early onset of other features of the metabolic syndrome 
(80,81). Given the burgeoning prevalence of noncommunica-
ble diseases worldwide, this additional contribution of preterm 
birth to the major noncommunicable diseases of adult life, 
and global clinical and economic burden, is worthy of strong 
emphasis.
Time Trends
In most countries with reliable data, preterm birth rates 
remain constant or are increasing; this coupled with popula-
tion growth will mean increasing numbers of preterm births 
each year (1,82). Changes in perinatal care over the past 50 
y have been substantial, and few countries have data on rates 
of impairment in preterm birth survivors across all gestational 
Figure 8. Regional burden of mortality and impairment for 15 million preterm babies born in 2010.
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age groups and in even fewer is it possible to track changes in 
rates of impairment over time. We attempted to address this 
by only including recent studies, and formal estimates of time 
trends in impairment after preterm birth were not undertaken. 
Data from Europe suggest that despite a reduction in risk of 
impairment at any gestational age, the absolute number of pre-
term survivors with cerebral palsy has not changed due to an 
increase in survival of the most preterm born infants (<26 wk) 
(83,84) (see Appendix at the end of this article). Improved 
quality of newborn care for all is needed to prevent increasing 
numbers of neonatal deaths and impaired survivors.
Data Limitations
Data availability varied with the least data from the highest 
burden settings. This is common to all the conditions consid-
ered in this supplement. Data on postneonatal child mortal-
ity (1–59 mo) after preterm birth were very sparse, especially 
from low-income settings, and it was not possible to estimate 
the number of survivors till the age of 5 years. We therefore 
applied the risk of impairment in those followed up at 2–5 y of 
age to all postneonatal survivors. Data were especially limited 
regarding the neurodevelopmental impairment. Published data 
on neurodevelopmental outcomes 2–5 y after preterm birth 
are not yet available for those born in 2010. We therefore have 
relied on outcome data for those born earlier in the decade. 
For neonates receiving NICU care in high- and intermediate-
mortality settings, few data were available. We explored the 
use of historical data from the 1980s in high-income countries 
before the widespread use of antenatal corticosteroids and sur-
factant; however, we elected to use the limited recent data from 
these high burden populations (Supplementary Information 
online). No data are available for those preterm postneonatal 
survivors who did not have access to NICU care who are likely 
to be at higher risk than the general term-born population. 
We conservatively applied the population risk of impairment 
for late preterm as a minimum biological risk (30). Historical 
data of the impairment risk in countries before modern NICU 
care suggest that the risk may be substantially higher than this 
(Supplementary Information online) (85).
Despite recent interest in moderate and late preterm births 
(32–33 and 34–36 wk, respectively), descriptive studies are 
heterogeneous in design, mainly from high-income countries 
and focused on more common, milder behavioral and school 
impairment outcomes (70,71). Limited recent population-
based data were available on absolute risk of impairment, and 
our estimates for late and moderate preterm outcomes are 
based on only two population-based cohorts (30,31). Although 
isolated mild motor impairment and mild motor impairment 
with cognitive impairment were taken into account, isolated 
cognitive impairment was not considered in estimating YLDs 
in GBD2010 for neonatal conditions. This is the most common 
outcome after extremely preterm birth and will be included in 
the future continuous GBD updates (86).
We included the sex of the baby in our assessment of preva-
lence of preterm birth, as this may influence survival and impair-
ment outcomes: preterm-born males are more likely to die or 
survive impaired at any given gestational age (19,25,83,87). 
However, insufficient data were available to be able to quantify 
the sex differences at each subsequent step of the model.
One notable challenge is the assessment of gestational age. The 
use of birth weight proxies may misclassify half of appropriately 
grown 27 wk babies who weigh >1,000 g, while misclassifying 
in the opposite direction more mature babies who are small for 
gestational age. In high-mortality settings, there may be a high 
proportion of babies who were over 28 wk and small for gesta-
tional age among survivors (88,89). An important priority is the 
development of accurate, practical tools to assess gestational age 
in low- and middle-income settings to increase the availability 
of data on outcome after preterm birth in these settings.
Data Improvement
The introduction and scale-up of neonatal intensive care in the 
United Kingdom in the 1970s prompted investment in follow-
up studies of NICU graduates (90). The need for information on 
long-term outcome remains critical not only for health-care plan-
ning but also for parents, particularly with ever advancing tech-
nologies in high-resource settings, and the scale-up of neonatal 
intensive care across middle income countries, with adoption in 
some low-income countries, especially in the private sector.
Preterm birth is a syndrome (91), and we expect outcomes 
to vary by underlying cause, with different outcomes from pre-
term labor/ruptured membranes (associated with infection), 
fetal growth restriction, preeclampsia, and provider-initiated 
preterm births as compared with those with rapid delivery 
following abruption or cervical incompetence. The propor-
tion impaired at any given gestational age may therefore vary 
between populations with different risk factors and cause pro-
files and recording a minimum level of granularity as to the 
preterm birth phenotype may improve data comparability (91).
The same factors leading to preterm birth can also affect the 
baby’s long-term outcome. Long-term outcomes are influenced 
by complex interactions between biological, medical, social, 
familial, and environmental factors, and their influence on the 
dynamic and adaptive maturational process of brain develop-
ment (28,92–94). Well-designed studies, capturing biological and 
social covariates, are required. The cohorts we identified showed 
substantial heterogeneity in context, care practices, and outcome 
reporting, for example, by birth weight or gestational age, at dif-
ferent ages of follow-up, using different assessment techniques 
and with variable rates of loss to follow-up (95). Some studies 
have reported higher rates of severe disability in those lost to fol-
low-up, resulting in ascertainment bias (96–99). More consistent 
and comprehensive tools and methods for describing outcomes, 
including milder behavioral and specific learning impairments 
are needed so that interventions can be targeted appropriately 
and findings across studies can be directly compared.
Programmatic Implications
This analysis has highlighted major geographical inequalities 
for babies’ outcomes and in the data to track these outcomes. 
There are three very different worlds that preterm babies 
are born into (5), reflecting a transition from high neonatal 
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mortality to preventable disability to the pushing on boundar-
ies of low gestational age (100):
1. Low-income and some middle-income countries still 
face high numbers of deaths even among late preterm 
babies. Of the two million deaths among preterm 
babies, 75% are estimated to occur in South Asia and 
sub-Saharan Africa, where preterm NMRs are six times 
those in high-income countries and hence mortality 
reduction remains the priority.
2. Many middle-income and emerging countries have 
made rapid reductions in NMR and are increasing the 
availability of neonatal intensive care, but the qual-
ity of care is variable. Our estimates suggest that these 
countries have high impairment rates in postneonatal 
survivors (e.g., almost half of very preterm postneo-
natal survivors in Central Asia and Latin America are 
estimated to have some long-term impairment). These 
impaired survivors are mainly not extremely preterm, 
and the majority of these disabilities should be prevent-
able with improved quality of care.
3. High-income countries have very low mortality and 
reducing gestational age–specific impairment risks over 
the past 20 y. For these countries, the focus in recent 
years has been on extremely preterm births (<26 wk) 
as these have the highest morbidity and mortality and 
pose difficult moral and ethical issues, and the increas-
ing recognition of the public health implications mod-
erate and late preterm babies.
We propose a three track approach: firstly, prevention of 
preterm birth; secondly, improved coverage and quality care 
for all babies born preterm to reduce mortality, morbidity, and 
impairment; and thirdly, early identification and care for sur-
vivors with disability.
Prevention of preterm birth is a knowledge gap given few 
evidence-based, high-impact options. Even in high-income set-
tings, the available approaches are challenging to implement 
and lead only to modest reductions in preterm birth (82). Early 
intervention with more focus on the social determinants of 
health—e.g., improving the nutritional status of female children, 
retaining adolescent girls in school, family planning, gender 
empowerment, smoking cessation, and in reduction in infec-
tions e.g., HIV and malaria on a population level—may have 
some benefit (101). However, strategic research is required to 
better understand and address the complex interplay between 
genetic and environmental factors leading to preterm birth (44).
Reducing deaths and long-term impairment among preterm 
babies will require improved coverage of quality maternity and 
overall neonatal care in all settings. This is challenging but is 
likely to be more cost effective than focusing on highly spe-
cialized neonatal intensive care in isolation (5). This will need 
changes in societal norms and culture—for example, improved 
maternal health; regular-quality antenatal care commencing 
early in pregnancy; high-quality facility birth with antenatal 
steroids to assist lung maturation if required (102); and essen-
tial newborn care, Kangaroo care, and postnatal visits.
Systems to improve follow-up of preterm babies will be impor-
tant to track the global burden and to allow appropriate prioriti-
zation of resources for health, education, and social care of those 
preterm born with disability. Priority has been placed in tracking 
outcomes of extreme preterm birth with the highest individual 
risk and more recently the relatively larger numbers of those 
born late preterm (34–36 wk). However, those born between 27 
and 33 wk are a considerable public health burden—we estimate 
nearly three times as many impaired postneonatal survivors 
after preterm birth at 28–31 wk as compared with those <28 wk. 
Investment in early years of research is likely to reap lifelong per-
sonal and economic benefits yet newborns and children remain 
underrepresented in research priorities (103).
table 4. Research in context regarding the burden of preterm birth
Data findings Preterm birth, before 37 completed weeks, presents a large burden worldwide with 15 million babies affecting in 2010 
accounting directly and indirectly for an estimated 2.0 million (uncertainty range 1.9–2.2 million) neonatal deaths and for 0.9 
million (uncertainty range 0.8–1.1 million) impaired survivors, 3.2% of the entire GBD.
Data for action Key programs priorities include:
Prevention of preterm birth must be strategically addressed; current solutions offer limited proof of impact. Urgent investments 
are required: in basic science regarding the causes of spontaneous preterm birth, in developing innovative solutions, and in 
better understanding of the patterns in low-income countries where infections and other risks are more prevalent.
Prevention of deaths and disability: Immediate burden reduction is possible through increasing coverage and the quality of care 
around the time of birth and in the postnatal period for women in preterm labor and their preterm babies.
Identification and care of survivors with disability.
Data gaps and 
improvements
Major gaps were found in the quantity and the quality of data to inform these estimates including:
Geographic gaps especially for high burden settings and population-based data.
Limitations in accuracy of assessment and reporting of gestational age, especially in settings without routine early ultrasound 
scanning in pregnancy.
Challenging data on impairment outcomes with variable metrics and tools across studies administered at different ages, further 
affected by high loss to follow-up in many cohort studies.
Actions/possible solutions: Increased awareness of the importance of gestational age assessments, and availability of simplified, 
low-cost gestational age assessment tools. Standardized reporting of impairment outcomes using, validated across settings.
GBD, global burden of disease.
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Conclusions
Preterm birth presents a large burden worldwide in terms of 
mortality and long-term physical and mental health and neu-
rodevelopmental impairment throughout later life. The data 
are least available where the burden is heaviest. Improved data 
collection, particularly from low- and middle-income coun-
tries, with standardization of assessment tools is needed to 
track this burden and evaluate the effectiveness of interven-
tions targeting preterm births (Table 4).
Improved care for preterm babies would reduce mortality 
especially in low-income countries, and this is still the largest 
part of the burden worldwide. Most babies who survive (>90%) 
are not impaired, and the current burden of disability could be 
reduced especially in middle-income settings improving the 
quality of neonatal care. Prevention of preterm birth should be 
a longer term priority, but major reduction in the global burden 
of mortality and morbidity following preterm birth could be 
made immediately with improved coverage and quality of care.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at 
http://www.nature.com/pr
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APPENDIX. TRENDS IN SURvIvAL AND MORBIDITY OF ThE MOST 
PRETERM BABIES (<26 WEEKS) IN hIGh-INCOME COUNTRIES
Survival for babies with very low gestational ages (24–26 weeks) has in-
creased with 80% survival at 25 weeks, although mortality and morbidity 
remains very high at the lower gestations (a). However, wide variation in 
survival rates exist, with the highest survival in very centralized services and 
where appropriate interventions to improve fetal and neonatal condition 
are used – such as antenatal corticosteroids, occlusive wrapping to prevent 
heat loss after birth and surfactant replacement therapy. Below 25 weeks 
outcome data are confounded by public policy and actual practice in the 
provision of care.
Disability free survival is around 60% at 26 weeks, 10% have severe disability 
at 3 years, and the proportion with disability rises at 25 weeks and below, as 
shown in national data in England for 2006 (b) (84). As these children sur-
vive for longer increasing proportions are found to have special educational 
needs and psychiatric problems (42,63).
The incremental costs attributable to preterm birth rise steeply at very low 
gestations (c). The costs are primarily attributable to neonatal intensive care 
due to prolonged hospital stay in survivors, discharge being at around 40 
weeks postmenstrual age, giving an average of 4 months care for the most 
immature. Later special educational special needs add lower costs but over 
a long time period.
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